# Progress Note 02 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Hubert H. Humphrey (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML022-SYN
- Date: 2026-02-03
- Fictional facility: St. Posthumous Health Center
- Fictional author: Walter Brandvold, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Four-week follow-up after cystectomy; appliance leaks and sore skin around the stoma; urology seen today. **S**

## History of present illness

Mr. Humphrey returns four weeks after his first visit, four months after his radical cystoprostatectomy. For three weeks his appliance has leaked about twice a week, usually at night, and the skin under the lower edge of the wafer has become red and sore. He has had no fever, flank pain, or blood in the urine. He saw Dr. Kowalczyk of urology this morning with the wound, ostomy, and continence nurse, who measured the stoma and fitted a convex wafer with a barrier ring, stoma powder for the irritated skin, and a night drainage bag. Dr. Kowalczyk reviewed the pathology and agreed that he needs no further treatment, and set out the surveillance schedule. Erections have not returned since the operation; he understands why and does not want treatment now. He is back at full-time work, walks 20 to 30 minutes a day, and his appetite is good. **S**

| Element | Detail |
|---|---|
| Stoma | Leaks twice a week; sore peristomal skin; refitted today |
| Urinary | No fever, flank pain, or blood in the urine |
| Coordination | Urology and stoma nurse seen today |
| Recovery | Working full time; walking daily; weight up 0.7 kg |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever or weight loss; energy improving |
| Genitourinary | Positive | Clear urine from the conduit; erectile dysfunction since surgery |
| Integumentary | Positive | Red, sore skin under the lower edge of the wafer |
| Gastrointestinal | Negative | Bowels regular; no abdominal pain |
| Psychiatric | Negative | Mood good; PHQ-2 score 0 |

5 systems reviewed. **S**

## Current medications

- No current medications. **S**

## Allergies

- No known allergy **S**

## Objective

BP 128/78 mmHg; pulse 72 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 97% on room air; weight 77.2 kg; BMI 23.8 kg/m². All vital signs are synthetic.

PHQ-2: 0. All results are synthetic.

## Physical examination

| System | Finding |
|---|---|
| General | Well |
| Abdomen | Soft and non-tender; healed midline incision; no incisional hernia |
| Stoma | Right lower abdomen; pink and moist; 28 mm, budded about 1.5 cm; moist erythema in a 1 cm band below the stoma, without satellite lesions; a skin crease below the stoma when sitting; no parastomal bulge on coughing |
| Extremities | No edema |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Bladder cancer after radical cystoprostatectomy, pT2a N0, no evidence of disease** (Z85.51). Organ-confined disease with negative nodes and margins; no adjuvant therapy is indicated. Surveillance as set out by urology. **S**
   - CT of the chest, abdomen, and pelvis with a urographic phase at one year after surgery, then every 6 to 12 months to three years.
   - Renal ultrasound at six months after surgery.
2. **Ileal conduit urostomy with appliance leaks and moisture dermatitis** (Z93.6). Leaks from a skin crease below the stoma when he sits; the irritation is from urine contact, not fungal. **S**
   - Convex wafer with a barrier ring, changed every three to four days; stoma powder sealed with a barrier film until the skin heals.
   - Night drainage bag.
   - Call the stoma nurse for any new leak.
3. **After cystectomy: kidney function and metabolic monitoring** (Z90.6). Creatinine 1.12 mg/dL and bicarbonate 22 mmol/L at the first visit, the post-operative baseline. **S**
   - Chemistry at six months after surgery.
   - About 2 liters of fluid a day.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Laboratory | Chemistry with creatinine, chloride, and bicarbonate | Every 3 to 6 months in the first year after diversion, then yearly | Up to date | Four weeks ago: creatinine 1.12 mg/dL, chloride 106, bicarbonate 22 mmol/L; next at six months after surgery |
| Laboratory | Vitamin B12 | Baseline, then yearly from two to three years after an ileal diversion | Up to date | 412 pg/mL four weeks ago |
| Imaging | CT of the chest, abdomen, and pelvis (with urographic phase) | Every 6 to 12 months for 2 to 3 years after cystectomy, then yearly | Due | Pre-operative staging showed no spread; first surveillance scan at one year after surgery |
| Imaging | Upper-tract imaging (renal ultrasound or CT urography) | Every 6 months to year 3, then yearly | Due | Renal ultrasound at six months after surgery, in about two months |
| Examination | Stoma and peristomal skin | Every visit | Completed today | Moisture dermatitis below the stoma from leaks; appliance refitted by the stoma nurse |
| Examination | Parastomal and incisional hernia | Every visit | Completed today | None |
| Survey | Distress and depression screen (PHQ-2) | Every visit | Completed today | PHQ-2 score 0 |
| Survey | Sexual function | After cystectomy and periodically | Completed today | Erectile dysfunction since surgery; options explained by urology; no treatment wanted now |
| Laboratory | Routine urine culture of conduit urine | Only for fever, flank pain, or other signs of infection | Not indicated | Bacteria are expected in conduit urine; no symptoms today |
| Laboratory | Urethral wash cytology | Periodically if the urethra is retained and at high risk | Not indicated | Urethral margin negative and no prostatic urethral involvement |
| Medication safety | Adjuvant systemic therapy | Offered for pT3 to pT4 or node-positive disease | Not indicated | pT2a N0 with negative margins |
| Referral | Urology and the wound, ostomy, and continence nurse | Once, then shared surveillance | Completed today | Seen today; recommendations in the consultation note |
| Self-management | Fluid intake and stoma self-care | Every visit | Completed today | About 2 liters a day; new appliance routine taught |

## Goal progress

- Leak-free urostomy appliance with healthy peristomal skin. In progress; target 2026-04-07. **S**
- Stable kidney function (creatinine within 0.3 mg/dL of the post-operative baseline) and bicarbonate 22 mmol/L or more. In progress; target 2026-07-07. **S**
- Regain stamina after surgery: walk 30 minutes a day and regain weight. In progress; target 2026-04-07. **S**
- Written survivorship surveillance schedule in place, shared between urology and primary care. In progress; target 2026-07-07. **S**

## Guideline basis

- Holzbeierlein J, et al. Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/SUO Guideline (2017; Amended 2020, 2024). J Urol 2024;212(1):3-10 (2024), American Urological Association, American Society of Clinical Oncology, and Society of Urologic Oncology
- NCCN Clinical Practice Guidelines in Oncology: Bladder Cancer (2026), National Comprehensive Cancer Network
- CMID: Clinical Monitoring Intelligence Database, urologic cancer monograph (2026), Aether Forge

## Follow-up

- Stoma nurse by telephone in one week. Primary care at six months after surgery with chemistry and a renal ultrasound. **S**
- Next scheduled visit 2026-04-07: six-month post-cystectomy follow-up: kidney function, acid-base, upper-tract ultrasound, and review after a kidney infection. **S**
